Lista de obras - Savino Bruno - Dominio Público Uruguay

A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection.

artículo científico publicado en 2007

A simple method for ascites concentration and reinfusion

artículo científico publicado en 1995

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

artículo científico publicado en 2008

Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

artículo científico publicado en 2013

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.

scientific article published on January 2009

Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy

artículo científico publicado en 1998

Current practice of chronic hepatitis B treatment in Southern Italy

artículo científico publicado en 2012

Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice

artículo científico publicado en 2011

Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities

artículo científico publicado en 1995

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

artículo científico publicado en 1998

Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

artículo científico publicado en 1984

Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

artículo científico publicado en 2012

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

artículo científico publicado en 2010

Futility of antiviral treatments for hepatitis C: An evolving concept entering the direct antiviral agents era ⬇️

artículo científico publicado el 24 de octubre de 2012

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

scientific journal article

HBV genotype must be included in treatment algorithm

HCV cirrhosis at the edge of decompensation: will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?

artículo científico publicado en 2014

Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.

artículo científico publicado en 2011

Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?

artículo científico publicado en 2017

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

artículo científico publicado en 2007

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

artículo científico publicado en 2009

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

artículo científico publicado en 1996

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

artículo científico publicado en 1997

Hepatitis C virus testing in primary biliary cirrhosis

artículo científico publicado en 1992

High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma

artículo científico publicado en 2018

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

artículo científico publicado en 1999

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.

artículo científico publicado en 2017

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

artículo científico publicado en 2005

Increased thrombin generation in inflammatory bowel diseases

artículo científico publicado en 2009

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2006

Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study

artículo científico publicado en 2014

Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.

artículo científico publicado en 2006

Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behaviour: Prospective comparison with pathology.

artículo científico publicado en 2017

Is response to antiviral treatment influenced by hepatitis B virus genotype?

scientific article published on 06 January 2010

Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis

artículo científico publicado en 1991

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

artículo científico publicado en 2008

Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals

artículo científico publicado en 2018

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

scientific article published on 01 March 1995

Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.

artículo científico publicado en 2001

Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients.

artículo científico publicado en 2015

Management of HCV patients with cirrhosis with direct acting antivirals.

artículo científico publicado en 2014

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

artículo científico publicado en 1995

Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens

artículo científico publicado en 2013

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy

artículo científico publicado en 2013

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

artículo científico publicado en 2009

Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients

artículo científico publicado en 2007

Optimal management of patients with chronic hepatitis C and comorbidities.

artículo científico

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

artículo científico publicado en 2013

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

artículo científico publicado en 2004

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study

artículo científico publicado en 2009

Properties of hepatitis B virus pre-S1 deletion mutants

artículo científico publicado en 1994

Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients

artículo científico publicado en 1997

Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach

scientific article published on 01 February 2001

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

artículo científico publicado en 2011

Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablation

artículo científico publicado en 2011

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

artículo científico publicado en 2012

Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

artículo científico publicado en 1987

Reply:

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.

artículo científico publicado en 2002

Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials

artículo científico publicado en 2014

Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis

artículo científico publicado en 2003

Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.

artículo científico publicado en 2007

Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C ⬇️

artículo científico publicado el 10 de abril de 2013

Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon

artículo científico publicado en 2003

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

artículo científico publicado en 2010

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

artículo científico publicado en 2007

The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis

artículo científico publicado en 2014

The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis.

artículo científico publicado en 1994

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

artículo científico publicado en 2006

The use of methotrexate for treatment of inflammatory bowel disease in clinical practice

artículo científico publicado en 2011

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.

artículo científico publicado en 2014

Unusual B cell morphology in inflammatory bowel disease

artículo científico publicado en 2012

Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosis

artículo científico publicado en 2013

Viral load in samples from hepatitis C virus (HCV)-infected patients with various clinical conditions

artículo científico publicado en 1995

Lista de obras de Savino Bruno

A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection.

A simple method for ascites concentration and reinfusion

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.

Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy

Current practice of chronic hepatitis B treatment in Southern Italy

Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice

Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

Futility of antiviral treatments for hepatitis C: An evolving concept entering the direct antiviral agents era ⬇️

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

HBV genotype must be included in treatment algorithm

HCV cirrhosis at the edge of decompensation: will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?

Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.

Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

Hepatitis C virus testing in primary biliary cirrhosis

High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

Increased thrombin generation in inflammatory bowel diseases

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study

Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.

Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behaviour: Prospective comparison with pathology.

Is response to antiviral treatment influenced by hepatitis B virus genotype?

Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.

Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients.

Management of HCV patients with cirrhosis with direct acting antivirals.

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients

Optimal management of patients with chronic hepatitis C and comorbidities.

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study

Properties of hepatitis B virus pre-S1 deletion mutants

Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients

Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablation

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

Reply:

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.

Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials

Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis

Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.

Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C ⬇️

Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis

The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis.

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

The use of methotrexate for treatment of inflammatory bowel disease in clinical practice

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.

Unusual B cell morphology in inflammatory bowel disease

Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosis

Viral load in samples from hepatitis C virus (HCV)-infected patients with various clinical conditions